KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Cash & Current Investments (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Cash & Current Investments for 17 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 10.32% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 10.32% year-over-year, with the annual reading at $1.3 billion for FY2025, 10.32% up from the prior year.
  • Cash & Current Investments hit $1.3 billion in Q4 2025 for Bausch Health Companies, down from $1.3 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.5 billion in Q1 2022 to a low of $497.0 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2023.
  • Biggest five-year swings in Cash & Current Investments: crashed 78.41% in 2023 and later skyrocketed 179.78% in 2025.
  • Year by year, Cash & Current Investments stood at $582.0 million in 2021, then increased by 1.55% to $591.0 million in 2022, then soared by 62.77% to $962.0 million in 2023, then grew by 24.84% to $1.2 billion in 2024, then rose by 10.32% to $1.3 billion in 2025.
  • Business Quant data shows Cash & Current Investments for BHC at $1.3 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.7 billion in Q2 2025.